SecBot SecBot
PRESS-RELEASE ·Filed Jun 9, 2026

TNGX

Tango Therapeutics, Inc.
BEARISH
Impact 6/10
Horizonimmediate Processed5mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

The $600M raise provides Tango with a multi-year cash runway, reducing near-term financing risk, but the ~13-15% dilution (including the option) is a material negative for existing shareholders. Monitor the stock's reaction at open, if it gaps down more than the dilution percentage, it suggests the market views this as a distressed or opportunistic raise. Watch for any pipeline updates or data readouts that could justify the capital need.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$28.68
T+0 close · Jun 9, 2026 · via day close
Latest settled
−20.64%
T+60 · $22.76
Vs SPY
−27.22%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 10 $28.68entry
  2. T+1 · 5mo ago +3.97%α +2.28% · $29.82
  3. T+5 · 5mo ago +12.13%α +8.70% · $32.16
  4. T+20 · 4mo ago +6.42%α +2.79% · $30.52
  5. T+60 · 2mo ago −20.64%α −27.22% · $22.76
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Tango Therapeutics priced a $600M underwritten offering of 18.2M common shares and pre-funded warrants at $30/share, with an underwriter option for an additional 3M shares. For a clinical-stage biotech with a $4.5B market cap, this represents ~13.3% dilution of current shares outstanding (excluding the option), providing substantial cash runway but signaling significant near-term dilution.

Key Financial Metrics

Deal Value
$600.0M

Key Facts

  • Priced 18,166,667 common shares at $30.00 per share
  • Priced pre-funded warrants for 1,833,395 shares at $29.999 each
  • Gross proceeds expected to be approximately $600 million
  • Underwriters granted 30-day option to purchase up to 3,000,009 additional shares
  • Offering expected to close on or about June 11, 2026
  • J.P. Morgan, Leerink Partners, Cantor and Stifel are joint bookrunning managers

Financial Impact

Approximately $600 million gross proceeds; dilution of ~13.3% based on 18.2M new shares vs. current outstanding (pre-funded warrants add ~1.3% more if exercised); underwriter option could add another ~2.2% dilution

dilutioncash runwayshare count

Risk Factors

  • Dilution of ~13-15% for existing shareholders
  • Potential further dilution if underwriters exercise the 3M-share option
  • Market may interpret large raise as signaling higher cash burn or pipeline delays
  • No stated use of proceeds, uncertainty about capital allocation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3309430

Track record

27 reports on TNGX

Performance horizon

2 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
  3. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
  4. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $21.50 Now $24.17 +12.42% settles Feb 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
  6. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
  8. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
  9. Aug 11, 202613w ago 8-K Bearish 6/10 Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
  10. Aug 11, 202613w ago 8-K Bullish 7/10 No price data
Showing 10 of 27

US Market Status

Market Closed · Opens in 9h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026